Infection Prevention Devices Market: Trends, Growth, and Forecast

Infection prevention devices are products that help reduce the risk of transmitting infectious diseases among patients, healthcare workers, and visitors. They include disinfectants, protective apparel, sterilization equipment, and other devices that prevent the spread of pathogens. Infection prevention devices are essential for ensuring the safety and quality of healthcare services, as well as reducing the healthcare costs associated with infections. 

According to a report by Research and Markets, the infection prevention devices market was valued at USD 19.31 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.6% from 2023 to 2032, reaching USD 36.67 billion by 2032. The report provides a comprehensive analysis of the market dynamics, size, forecast, segmentation, competitive landscape, and regional analysis of the infection prevention devices market. In this blog post, we will summarize the key findings of the report and highlight the opportunities and challenges for the market players. 

Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/infection-prevention-devices-market/requestsample 

Market Dynamics 

The infection prevention devices market is driven by several factors, such as the rising need for disease prevention over cure, the increasing healthcare costs, the technological advancements in infection prevention devices, and the growing focus on healthcare infrastructure development. However, the market also faces some restraints, such as stringent regulatory requirements and limited awareness in developing regions. 

The rising need for disease prevention over cure: The global burden of infectious diseases is increasing due to factors such as population growth, urbanization, climate change, and antimicrobial resistance. According to the World Health Organization (WHO), infectious diseases account for about 17% of all deaths worldwide, and more than 25% of the global disability-adjusted life years (DALYs). Infection prevention devices can help reduce the transmission of infectious diseases and improve the health outcomes of patients and healthcare workers. 

The increasing healthcare costs: The economic impact of infections is significant, as they increase the length of hospital stay, the use of antibiotics, the risk of complications, and the mortality rate. According to a study by Zimlichman et al. (2013), the annual cost of healthcare-associated infections (HAIs) in the US was estimated at USD 9.8 billion, with surgical site infections, ventilator-associated pneumonia, and central line-associated bloodstream infections being the most costly. Infection-prevention devices can help lower healthcare costs by preventing infections and reducing the need for additional treatments. 
The technological advancements in infection prevention devices: The infection prevention devices market is witnessing the introduction of innovative products that offer better performance, convenience, and safety. For example, Medline Industries, LP, a leading player in the market, launched the ReadyPrep CHG Cloth, a pre-saturated cloth that delivers 2% chlorhexidine gluconate (CHG) to the skin for preoperative skin preparation. The cloth is designed to reduce the risk of surgical site infections, improve patient comfort, and save time and resources. 

The growing focus on healthcare infrastructure development: The infection prevention devices market is also benefiting from the increasing investments in healthcare infrastructure, especially in emerging markets such as Asia Pacific, Latin America, and the Middle East and Africa. These regions are witnessing a rapid growth in the demand for healthcare services, driven by factors such as the rising population, the aging demographic, the growing middle class, and the improving healthcare access. The development of healthcare infrastructure requires the adoption of infection-prevention devices to ensure the safety and quality of healthcare delivery. 

However, the infection prevention devices market also faces some challenges, such as stringent regulatory requirements and limited awareness in developing regions. The infection prevention devices market is subject to various regulations and standards that govern the safety, efficacy, and quality of the products. The market players have to comply with the regulatory requirements of different countries and regions, which can increase the time and cost of product development and approval. Moreover, the limited awareness and education about the importance and benefits of infection prevention devices in some developing regions can hamper the market growth. The market players have to invest in marketing and training activities to increase the awareness and adoption of infection-prevention devices among the end-users. 

Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/infection-prevention-devices-market

Market Size and Forecast 

The global infection prevention devices market was valued at USD 19.31 billion in 2023 and is expected to grow at a CAGR of 7.6% from 2023 to 2032, reaching USD 36.67 billion by 2032. The market growth is attributed to the factors discussed above, as well as the increasing prevalence of chronic diseases, the rising number of surgical procedures, and the growing demand for home care and outpatient settings. 

The infection prevention devices market is segmented by product type and end-user. By product type, the market is divided into disinfectants, protective apparel, sterilization equipment, and other devices. The disinfectants segment accounted for the largest share of the market in 2023, owing to the wide application of disinfectants in various healthcare settings and the availability of various types of disinfectants, such as alcohols, aldehydes, oxidizing agents, phenolics, quaternary ammonium compounds, and others. The protective apparel segment is expected to witness the fastest growth during the forecast period, due to the increasing demand for personal protective equipment (PPE) amid the COVID-19 pandemic and the rising awareness about the importance of infection prevention among healthcare workers and patients. The sterilization equipment segment is also expected to grow significantly, as the need for sterilizing medical instruments and devices increases with the rising number of surgical procedures and the emergence of new pathogens. 

By end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2023, as hospitals are the major consumers of infection prevention devices, given the high volume of patients, procedures, and infections. The hospital segment is also expected to maintain its dominance during the forecast period, as the demand for infection prevention devices in hospitals remains high due to the ongoing COVID-19 pandemic and the increasing incidence of HAIs. The clinics segment is projected to grow at the highest CAGR during the forecast period, as the number of clinics and outpatient facilities increases with the growing preference for minimally invasive and cost-effective treatments. The ambulatory surgical centers segment is also expected to grow significantly, as the number of ambulatory surgical centers increases with the rising demand for same-day surgeries and the advancement of surgical technologies. 

Competitive Landscape 

The infection prevention devices market is highly competitive and fragmented, with the presence of several local and global players. The key players in the market include Medline Industries, LP, Cardinal Health, Paul Hartmann AG, Mölnlycke Health Care AB, The 3M Company, B. Braun Melsungen AG, Coloplast Group, Becton, Dickinson, and Company, Hollister Incorporated, Medical Devices Business Services, Inc. (Johnson & Johnson). These players compete based on product innovation, quality, price, distribution, and customer service. They also engage in mergers, acquisitions, and partnerships to expand their product portfolio, geographic presence, and customer base. 

Some of the notable developments in the market are: 

In March 2021, Medline Industries, LP acquired the Namic fluid management business from AngioDynamics, Inc., a provider of minimally invasive medical devices. The acquisition enhanced Medline's portfolio of infection-prevention devices for interventional radiology and cardiology procedures. 

In February 2021, Cardinal Health launched the Presource Kits Program, a customized solution that provides pre-packaged kits of infection prevention devices for various healthcare settings. The program aimed to help healthcare providers reduce waste, save time, and improve patient safety. 
In January 2021, Paul Hartmann AG launched the HydroClean Plus Dressing, a wound dressing that combines the benefits of hydrogel and superabsorbent polymer technologies. The dressing offered superior infection prevention and wound healing properties. 

In December 2020, Mölnlycke Health Care AB introduced the Biogel PI UltraTouch S Surgical Glove, a synthetic polyisoprene glove that offered enhanced sensitivity, comfort, and protection. The glove was designed to prevent the risk of allergic reactions and infections during surgical procedures. 

In November 2020, The 3M Company launched the 3M Attest Super Rapid Readout Biological Indicator, a device that provided faster and more reliable results for steam sterilization verification. The device reduced the readout time from 24 hours to 30 minutes, enabling faster infection prevention and quality assurance. 
Market Segmentation 

The infection prevention devices market is segmented by product type, end-user, and region. The following table summarizes the market segmentation and the market size and forecast for each segment. 

Recent Developments 

The infection prevention devices market is constantly evolving with the introduction of new products, regulations, and trends. Some of the recent developments in the market are: 

In April 2021, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the STERIS V-PRO 1 Plus, maX, and maX2 Low-Temperature Sterilization Systems, which are devices that use vaporized hydrogen peroxide to sterilize certain respirators for reuse during the COVID-19 pandemic. The EUA aimed to increase the availability of infection-prevention devices and reduce the risk of exposure to SARS-CoV-2, the virus that causes COVID-19. 

In March 2021, Becton, Dickinson, and Company announced the launch of the BD Kiestra InoqulA+ specimen processor, an automated device that inoculates and incubates microbiology specimens for culture. The device improved the efficiency, accuracy, and safety of infection prevention and diagnosis. 

In February 2021, Coloplast Group acquired Nine Continents Medical, Inc., a US-based company that develops and markets an innovative device for treating urinary retention. The device, called the Tibion Bionic Leg, is a wearable robotic device that stimulates the nerves and muscles of the lower leg to help patients empty their bladder. The device offered a non-invasive and infection-free alternative to catheterization and surgery. 

In January 2021, Hollister Incorporated launched the VaPro Plus Pocket Touch Free Hydrophilic Intermittent Catheter, a device that provides a touch-free catheterization experience for patients with urinary incontinence. The device featured a protective tip and sleeve, a hydrophilic coating, and a discreet pocket-sized package. The device aimed to reduce the risk of urinary tract infections and improve the quality of life of patients. 

In December 2020, Medical Devices Business Services, Inc. (Johnson & Johnson) acquired the remaining stake in Verb Surgical Inc., a company that develops and markets a digital surgery platform that combines robotics, advanced visualization, data analytics, and connectivity. The acquisition strengthened Johnson & Johnson's position in the infection prevention devices market, as the digital surgery platform offered enhanced infection prevention and surgical outcomes. 

Regional Analysis 

The infection prevention devices market is geographically segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The following table summarizes the market trends and dynamics in each region. 

Region 

Trends and Dynamics 

North America

North America is the largest and most mature market for infection prevention devices, owing to the high prevalence of infectious diseases, the well-established healthcare infrastructure, the stringent regulatory standards, and the presence of key market players. The market is expected to grow steadily during the forecast period, as the demand for infection prevention devices remains high amid the COVID-19 pandemic and the increasing incidence of HAIs. The US is the dominant country in the region, accounting for more than 80% of the market share, followed by Canada and Mexico. 

Europe 

Europe is the second-largest market for infection prevention devices, driven by the high awareness and adoption of infection prevention devices, the increasing healthcare expenditure, the rising geriatric population, and the growing number of surgical procedures. The market is expected to grow moderately during the forecast period, as the region recovers from the impact of the COVID-19 pandemic and the Brexit uncertainty. The UK, Germany, France, Italy, and Spain are the leading countries in the region, contributing to more than 70% of the market share. 

Asia Pacific 

Asia Pacific is the fastest-growing market for infection prevention devices, owing to the rapid growth in the demand for healthcare services, the increasing disposable income, the improving healthcare access, and the rising prevalence of chronic and infectious diseases. The market is expected to grow significantly during the forecast period, as the region invests in healthcare infrastructure development, adopts advanced infection prevention technologies, and implements stringent infection control policies. China, India, Japan, Australia, and South Korea are the major countries in the region, accounting for more than 80% of the market share. 

Latin America 

Latin America is an emerging market for infection prevention devices, driven by the growing population, urbanization, increasing healthcare expenditure, and rising awareness about infection prevention. The market is expected to grow at a high CAGR during the forecast period, as the region faces the challenges of the COVID-19 pandemic, social and political instability, and the high burden of infectious diseases. Brazil, Mexico, Argentina, and Colombia are the key countries in the region, representing more than 70% of the market share. 

Middle East 

The Middle East is a potential market for infection prevention devices, driven by the increasing medical tourism, the expanding healthcare sector, and the growing demand for quality healthcare services. The market is expected to grow at a moderate CAGR during the forecast period, as the region copes with the COVID-19 pandemic, the oil price fluctuations, and the geopolitical tensions. Saudi Arabia, UAE, Israel, and Turkey are the leading countries in the region, contributing to more than 80% of the market share. 

Africa 

Africa is the smallest and least developed market for infection prevention devices, owing to the low awareness and adoption of infection prevention devices, the limited healthcare infrastructure, the lack of skilled healthcare workers, and the high poverty and disease burden. The market is expected to grow at a low CAGR during the forecast period, as the region struggles with the COVID-19 pandemic, the economic and social challenges, and the lack of adequate infection control measures. South Africa, Egypt, Nigeria, and Kenya are the main countries in the region, representing more than 60% of the market share. 

Future Outlook 

The infection prevention devices market is expected to witness robust growth in the coming years, as the need for infection prevention and control becomes more critical in the wake of the COVID-19 pandemic and the emergence of new pathogens. The market players are expected to leverage the opportunities offered by technological advancements, healthcare infrastructure development, and the increasing demand for infection prevention devices in various healthcare settings. However, the market players are also expected to face some challenges, such as regulatory hurdles, competitive pressure, and awareness and education gaps in some regions. The market players are advised to adopt the following strategies to succeed in the market: 

Focus on product innovation and differentiation: The market players should invest in research and development to introduce new and improved products that offer better performance, convenience, and safety. The market players should also differentiate their products from the competitors by highlighting their unique features, benefits, and value propositions. 
Expand the product portfolio and geographic presence: The market players should expand their product 

Related Report:

Cough Syrup Market
https://www.expertmarketresearch.com/reports/cough-syrup-market
Bronchial Spasms Treatment Market
https://www.expertmarketresearch.com/reports/bronchial-spasms-treatment-market
Chronic Fatigue Syndrome Treatment Market
https://www.expertmarketresearch.com/reports/chronic-fatigue-syndrome-treatment-market
Traveller's Diarrhoea Treatment Market
https://www.expertmarketresearch.com/reports/travellers-diarrhoea-treatment-market
Bruton's Tyrosine Kinase (BTK) Inhibitors Market
https://www.expertmarketresearch.com/reports/brutons-tyrosine-kinase-btk-inhibitors-market

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.